Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1967 1
1969 1
1971 1
1973 2
1985 1
1988 1
1989 2
1990 5
1991 4
1992 6
1993 1
1994 2
1995 1
1999 1
2000 1
2001 3
2002 1
2003 6
2004 2
2005 4
2006 9
2007 12
2008 14
2009 12
2010 20
2011 14
2012 21
2013 30
2014 41
2015 38
2016 45
2017 54
2018 57
2019 49
2020 56
2021 46
2022 57
2023 21

Text availability

Article attribute

Article type

Publication date

Search Results

557 results

Results by year

Filters applied: . Clear all
Page 1
The nephropathy of sickle cell trait and sickle cell disease.
Ataga KI, Saraf SL, Derebail VK. Ataga KI, et al. Among authors: saraf sl. Nat Rev Nephrol. 2022 Jun;18(6):361-377. doi: 10.1038/s41581-022-00540-9. Epub 2022 Feb 21. Nat Rev Nephrol. 2022. PMID: 35190716 Free PMC article. Review.
Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC.
Awad MM, Gadgeel SM, Borghaei H, Patnaik A, Yang JC, Powell SF, Gentzler RD, Martins RG, Stevenson JP, Altan M, Jalal SI, Panwalkar A, Gubens M, Sequist LV, Saraf S, Zhao B, Piperdi B, Langer CJ. Awad MM, et al. Among authors: saraf s. J Thorac Oncol. 2021 Jan;16(1):162-168. doi: 10.1016/j.jtho.2020.09.015. Epub 2020 Oct 15. J Thorac Oncol. 2021. PMID: 33069888 Free article. Clinical Trial.
Dupuytren's disease.
Saraf S. Saraf S. Indian J Dermatol Venereol Leprol. 2010 May-Jun;76(3):291-3. doi: 10.4103/0378-6323.62985. Indian J Dermatol Venereol Leprol. 2010. PMID: 20445309 Free article. Review. No abstract available.
Multiplex immunohistochemistry/immunofluorescence (mIHC/IF) for PD-L1 testing in triple-negative breast cancer: a translational assay compared with conventional IHC.
Yeong J, Tan T, Chow ZL, Cheng Q, Lee B, Seet A, Lim JX, Lim JCT, Ong CCH, Thike AA, Saraf S, Tan BYC, Poh YC, Yee S, Liu J, Lim E, Iqbal J, Dent R, Tan PH. Yeong J, et al. Among authors: saraf s. J Clin Pathol. 2020 Sep;73(9):557-562. doi: 10.1136/jclinpath-2019-206252. Epub 2020 Jan 22. J Clin Pathol. 2020. PMID: 31969377
Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial.
Chan ATC, Lee VHF, Hong RL, Ahn MJ, Chong WQ, Kim SB, Ho GF, Caguioa PB, Ngamphaiboon N, Ho C, Aziz MASA, Ng QS, Yen CJ, Soparattanapaisarn N, Ngan RK, Kho SK, Tiambeng MLA, Yun T, Sriuranpong V, Algazi AP, Cheng A, Massarelli E, Swaby RF, Saraf S, Yuan J, Siu LL. Chan ATC, et al. Among authors: saraf s. Ann Oncol. 2023 Mar;34(3):251-261. doi: 10.1016/j.annonc.2022.12.007. Epub 2022 Dec 16. Ann Oncol. 2023. PMID: 36535566 Clinical Trial.
Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma.
Ng HHM, Lee RY, Goh S, Tay ISY, Lim X, Lee B, Chew V, Li H, Tan B, Lim S, Lim JCT, Au B, Loh JJH, Saraf S, Connolly JE, Loh T, Leow WQ, Lee JJX, Toh HC, Malavasi F, Lee SY, Chow P, Newell EW, Choo SP, Tai D, Yeong J, Lim TKH. Ng HHM, et al. Among authors: saraf s. J Immunother Cancer. 2020 Aug;8(2):e000987. doi: 10.1136/jitc-2020-000987. J Immunother Cancer. 2020. PMID: 32847986 Free PMC article.
Fire-breathing burn.
Saraf S. Saraf S. Indian Dermatol Online J. 2012 Jan;3(1):73-4. doi: 10.4103/2229-5178.93491. Indian Dermatol Online J. 2012. PMID: 23130274 Free PMC article. No abstract available.
Update on meningiomas.
Saraf S, McCarthy BJ, Villano JL. Saraf S, et al. Oncologist. 2011;16(11):1604-13. doi: 10.1634/theoncologist.2011-0193. Epub 2011 Oct 25. Oncologist. 2011. PMID: 22028341 Free PMC article. Review.
Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced, PD-L1-positive papillary or follicular thyroid cancer.
Mehnert JM, Varga A, Brose MS, Aggarwal RR, Lin CC, Prawira A, de Braud F, Tamura K, Doi T, Piha-Paul SA, Gilbert J, Saraf S, Thanigaimani P, Cheng JD, Keam B. Mehnert JM, et al. Among authors: saraf s. BMC Cancer. 2019 Mar 4;19(1):196. doi: 10.1186/s12885-019-5380-3. BMC Cancer. 2019. PMID: 30832606 Free PMC article. Clinical Trial.
557 results